Fight Over Waze? Way
Health Care: Health Services
Derma Sciences Inc. (DSCI: NASDAQ)
$14.01 0.20 | 1.45%
05/24/13 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 18.50 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 35.60 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 14.10 | 12.50 |
| Beta | 1.00 | 0.81 | 0.98 |
| Price to Sales (TTM) | 3.12 | 2.58 | 1.42 |
| Price to Book (MRQ) | 2.63 | 3.22 | 2.41 |
| Price to Tangible Book (MRQ) | 3.93 | 10.53 | 5.08 |
| Price to Cash Flow (TTM) | -13.70 | 12.80 | 9.80 |
| Price to Free Cash Flow (TTM) | -7.70 | 82.50 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.90 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 1.40 | 2.30 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 15.74 | 2.80 |
| Payout Ratio (TTM) | 0.00 | 27.00 | 37.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 23.00 | 18.60 | 0.30 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 16.00 | 17.10 | 2.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 11.83 | -5.45 | 3.66 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 83.70 | 98.00 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 83.70 | 98.00 |
| EPS - 5 Yr Growth Rate (%) | n.a. | 11.05 | 8.04 |
| Capital Spending - 5 Yr Growth Rate (%) | 22.27 | 10.13 | 3.85 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 6.30 | 1.70 | 1.10 |
| Current Ratio (MRQ) | 8.40 | 2.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.41 | 0.73 |
| Total Debt to Equity (MRQ) | 0.00 | 0.46 | 0.86 |
| Interest Coverage (TTM) | n.a. | 14.80 | 6.80 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 40.40 | 62.00 | 47.70 |
| Gross Margin - 5 Yr Avg | 35.60 | 59.10 | 47.00 |
| EBITD Margin (TTM) | -18.00 | 24.90 | 19.40 |
| EBITD - 5 Yr Avg | -1.60 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -23.80 | 17.70 | 11.70 |
| Pre-Tax Margin - 5 Yr Avg | -8.90 | 14.70 | 10.20 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -27.70 | 0.14 | 0.09 |
| Net Profit Margin - 5 Yr Avg | -8.30 | 11.20 | 6.40 |
| Return on Assets (TTM) | -21.10 | 9.10 | 3.30 |
| Return on Assets - 5 Yr Avg | -8.90 | 6.90 | 2.30 |
| Return on Investment (TTM) | -23.00 | 12.70 | 8.70 |
| Return on Investment - 5 Yr Avg | -10.80 | 9.60 | 6.00 |
| Efficiency | |||
| Revenue/Employee (TTM) | 321,353.00 | n.a. | n.a. |
| Net Income/Employee (TTM) | -89,060.00 | n.a. | n.a. |
| Receivable Turnover (TTM) | 12.60 | 6.60 | 7.90 |
| Inventory Turnover (TTM) | 3.60 | 2.70 | 7.70 |
| Asset Turnover (TTM) | 1.00 | 0.70 | 0.40 |
Portfolios with DSCI
- Portfolio NameUser Type
- UserMedical devices M&A
- Contributor3 Small-Cap Stocks on Insid...
- Contributor10 Biotech Stocks Loved and...
- Contributor11 Biotech Stocks Loved or ...
- UserTest Drive
- Contributor10 Cheap Biotech Stocks Tha...
- Contributor5 Health Care Stocks With U...
- ContributorBarron's Insider Purchases ...
- UserPINOCH
Latest DSCI Headlines from TheStreet
- DSCI January 2014 Options Begin Trading 05.20.13 | 03:05 pm
- 5 Stocks That Make Prime Acquisition Targets 05.22.12 | 08:05 am
- 3 Small-Cap Stocks on Insiders' Radar 11.18.11 | 01:11 pm
- Insiders Trading BBBY, ENTG, DSCI, CHKM 10.20.11 | 10:10 am
- 11 Biotech Stocks Loved or Hated by Hedge Funds 08.17.11 | 06:08 am
- Biotech Stock Mailbag: Ranking Cheap Biotechs 07.01.11 | 08:07 am
- 10 Cheap Biotech Stocks That Could Soar 06.28.11 | 07:06 am
- Insiders Trading NS, TZOO, DSCI, CRR 05.28.11 | 03:05 pm
- Biotech Stock Mailbag: Fibrocell Science 05.27.11 | 06:05 am
- Derma Stock Soars (DSCI) 05.25.11 | 10:05 am
Press Releases for DSCI
- Derma Sciences Announces Timing For Fourth Quarter Conference Call And 2012 Form 10-K Filing - Business Wire 03.15.13 | 04:03 pm
- Derma Sciences To Present At The 25th Annual ROTH Conference - Business Wire 03.14.13 | 12:03 pm
- Derma Sciences Initiates Enrollment In DSC127 Phase 3 Trial For Healing Diabetic Foot Ulcers - Business Wire 02.06.13 | 08:02 am
- Derma Sciences Closes $36.4 Million Underwritten Public Offering Of Common Stock, Including Full Over-Allotment - Business Wire 12.11.12 | 05:12 pm
- Derma Sciences Announces Pricing Of Underwritten Public Offering Of Common Stock - Business Wire 12.06.12 | 09:12 am
- Derma Sciences Announces Commencement Of Public Offering Of Common Stock - Business Wire 12.05.12 | 04:12 pm
- Derma Sciences To Present At Two Upcoming Conferences - Business Wire 11.30.12 | 02:11 pm
- Derma Sciences To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.20.12 | 08:11 am
- Derma Sciences To Present At The Lazard Capital Markets 9th Annual Healthcare Conference - Business Wire 11.12.12 | 10:11 am
- Derma Sciences Reports Third Quarter 2012 Financial Results - Business Wire 11.12.12 | 07:11 am
Partner Headlines for DSCI
- Pre-Market Earnings Report for May 16, 2013 : WMT, KSS, FLO, CAE, BRC, PBH, IMOS, DANG, DSCI, SOL, CTCH - NASDAQ 05.15.13 | 08:05 pm
- Pre-Market Earnings Report for April 1, 2013 : CALM, DSCI - NASDAQ 03.28.13 | 08:03 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 12.04.12 | 09:12 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 11.29.12 | 09:11 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.20.12 | 09:11 am
- Do These Small-Cap Insiders Know Something You Don't? - Seeking Alpha 11.20.11 | 08:11 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 09.12.11 | 09:09 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 03.31.11 | 09:03 am
